ORMP Q3'26 Earnings: revenue estimate is 0 USD
Moins d'1 minute de lecture
ORMP (Oramed Pharmaceuticals Inc.) is set to announce its Q3'26 results on November 16, time not specified. The earnings are expected to be disclosed at 7:00 AM ET (12:00 PM UTC).
For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at 0.43 USD. Learn more details at ORMP Financials page.
Revenue & EPS values are provided in USD
| Q3'25 | Q4'25 | Q1'26 | Q2'26 | Q3'26 | |
|---|---|---|---|---|---|
| Revenue Reported | — | — | — | — | — |
| Revenue Estimate | — | — | — | — | — |
| Revenue Surprise | |||||
| EPS Reported | 0.00 | 0.91 | 2.76 | ||
| EPS Estimate | (0.04) | (0.08) | 0.43 | 0.43 | |
| EPS Surprise | +100.00% | +541.86% |
Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc.